• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎与原发性胆汁性肝硬化的肝移植:并发症及结局比较

Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome.

作者信息

Strasser S, Sheil A G, Gallagher N D, Waugh R, McCaughan G W

机构信息

A. W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, New South Wales, Australia.

出版信息

J Gastroenterol Hepatol. 1993 May-Jun;8(3):238-43. doi: 10.1111/j.1440-1746.1993.tb01193.x.

DOI:10.1111/j.1440-1746.1993.tb01193.x
PMID:8518394
Abstract

Primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) are the most common cholestatic disorders in adulthood requiring hepatic transplantation. Although they run similar courses, they may have different problems before and after transplantation. The aim of this study was to compare pre- and post-transplant complications and outcomes in these two similar but distinct patient groups. One hundred and seventeen adult patients underwent liver transplantation at our institution over a 6 year period, including 19 with PSC and 20 with PBC. Pre-transplant there were no significant differences in age, liver biochemistry, haematology or Child-Pugh scores between the two groups. The mean duration of disease before transplant was longer in PSC patients (11.7 vs 6.5 years; P < 0.05). The prevalence of septic cholangitis was greater in PSC (58 vs 5%; P < 0.01) as was the requirement for surgical or radiological interventional procedures, excluding cholecystectomy (53 vs 0%; P < 0.01). At transplantation, four patients with PSC had previously unrecognized cholangiocarcinoma. In the pre-transplant period these four patients had uncontrolled biliary sepsis at the time of transplant vs five of 15 PSC patients without cholangiocarcinoma. Postoperatively, PSC patients had a greater prevalence of intra-abdominal sepsis requiring surgical or radiological intervention (42 vs 5%; P < 0.05). In comparison, patients with PBC had a high prevalence of skeletal complications (30 vs 10%; P < 0.05) particularly avascular necrosis (15 vs 0%). The prevalence of chronic rejection was similar in both groups (15%). Overall survival was higher in PBC patients (85 vs 63%; P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

原发性硬化性胆管炎(PSC)和原发性胆汁性肝硬化(PBC)是成年期最常见的需要肝移植的胆汁淤积性疾病。尽管它们病程相似,但在移植前后可能存在不同问题。本研究的目的是比较这两个相似但不同的患者群体移植前后的并发症及结局。在6年期间,117例成年患者在我们机构接受了肝移植,其中19例为PSC患者,20例为PBC患者。移植前,两组在年龄、肝脏生化指标、血液学指标或Child-Pugh评分方面无显著差异。PSC患者移植前疾病的平均持续时间更长(11.7年对6.5年;P<0.05)。PSC患者中化脓性胆管炎的患病率更高(58%对5%;P<0.01),除胆囊切除外的手术或放射介入治疗需求也更高(53%对0%;P<0.01)。移植时,4例PSC患者此前未被识别出胆管癌。在移植前阶段,这4例患者在移植时存在未控制的胆系感染,而15例无胆管癌的PSC患者中有5例存在该情况。术后,PSC患者腹腔内感染需要手术或放射介入治疗的患病率更高(42%对5%;P<0.05)。相比之下,PBC患者骨骼并发症的患病率较高(30%对10%;P<0.05),尤其是无血管性坏死(15%对

相似文献

1
Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome.原发性硬化性胆管炎与原发性胆汁性肝硬化的肝移植:并发症及结局比较
J Gastroenterol Hepatol. 1993 May-Jun;8(3):238-43. doi: 10.1111/j.1440-1746.1993.tb01193.x.
2
Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - Impact of changes in allocation policy.胆汁淤积性肝病患者的候补名单死亡率和移植后生存率 - 分配政策变化的影响。
HPB (Oxford). 2018 Oct;20(10):916-924. doi: 10.1016/j.hpb.2018.03.013. Epub 2018 Jun 21.
3
Surgical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎的外科治疗
Clin Rev Allergy Immunol. 2005 Apr;28(2):167-74. doi: 10.1385/CRIAI:28:2:167.
4
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.原发性硬化性胆管炎的原位肝移植:单中心12年经验
Ann Surg. 1997 May;225(5):472-81; discussion 481-3. doi: 10.1097/00000658-199705000-00004.
5
Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.原发性硬化性胆管炎患者肝移植的长期预后:与原发性胆汁性胆管炎的对比分析。
Am J Gastroenterol. 2004 Mar;99(3):538-42. doi: 10.1111/j.1572-0241.2004.04050.x.
6
Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.原发性硬化性胆管炎患者接受死后循环死亡供肝肝移植的临床结局。
J Hepatol. 2017 Nov;67(5):957-965. doi: 10.1016/j.jhep.2017.06.027. Epub 2017 Jul 8.
7
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎肝移植的选择与时机
Hepatology. 1992 Nov;16(5):1290-9.
8
Liver transplantation in PBC and PSC: indications and disease recurrence.原发性胆汁性胆管炎和原发性硬化性胆管炎的肝移植:适应证和疾病复发。
Clin Res Hepatol Gastroenterol. 2011 Jun;35(6-7):446-54. doi: 10.1016/j.clinre.2011.02.007. Epub 2011 Apr 1.
9
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.原发性胆汁性肝硬化和原发性硬化性胆管炎的肝移植:用自然史模型预测预后
Mayo Clin Proc. 1998 Jun;73(6):575-88. doi: 10.4065/73.6.575.
10
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?原发性胆汁性肝硬化和原发性硬化性胆管炎的肝移植:药物治疗会改变时机和选择吗?
Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S9-17.

引用本文的文献

1
Gut Microbiome and Bile Acid Interactions: Mechanistic Implications for Cholangiocarcinoma Development, Immune Resistance, and Therapy.肠道微生物群与胆汁酸的相互作用:对胆管癌发生、免疫抵抗和治疗的机制影响
Am J Pathol. 2025 Mar;195(3):397-408. doi: 10.1016/j.ajpath.2024.11.004. Epub 2024 Dec 19.
2
Time spent in hospital after liver transplantation: Effects of primary liver disease and comorbidity.肝移植术后住院时间:原发性肝病及合并症的影响
World J Transplant. 2016 Dec 24;6(4):743-750. doi: 10.5500/wjt.v6.i4.743.
3
Cholangiocarcinoma Secondary to Primary Sclerosing Cholangitis in Explanted Livers: A Single-Center Study in the South of Iran.
移植肝中继发于原发性硬化性胆管炎的胆管癌:伊朗南部的一项单中心研究
Hepat Mon. 2015 Dec 27;15(12):e33626. doi: 10.5812/hepatmon.33626. eCollection 2015 Dec.
4
Drug therapy of primary biliary diseases: classical and modern strategies.原发性胆汁性疾病的药物治疗:经典与现代策略
J Cell Mol Med. 2001 Jan-Mar;5(1):98-115. doi: 10.1111/j.1582-4934.2001.tb00144.x.